BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25444432)

  • 1. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
    Okada A; Koike H; Nakamura T; Motomura M; Sobue G
    Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Suzuki S
    Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
    Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
    Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seronegative nonparaneoplastic Lambert-Eaton myasthenic syndrome].
    Sanadze AG; Sidnev DV; Tumurov DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):77-80. PubMed ID: 28638036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
    Martin-Moutot N; de Haro L; Seagar M
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert-Eaton myasthenic syndrome in children.
    Tsao CY; Mendell JR; Friemer ML; Kissel JT
    J Child Neurol; 2002 Jan; 17(1):74-6. PubMed ID: 11913581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
    Martin-Moutot N; De Haro L; Seagar M
    J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apheresis treatment in Lambert-Eaton myasthenic syndrome.
    Motomura M; Hamasaki S; Nakane S; Fukuda T; Nakao YK
    Ther Apher; 2000 Aug; 4(4):287-90. PubMed ID: 10975475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment.
    Rigamonti A; Lauria G; Stanzani L; Mantero V; Andreetta F; Salmaggi A
    J Neurol Sci; 2014 Jan; 336(1-2):169-70. PubMed ID: 24215945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice.
    Martín-García E; Mannara F; Gutiérrez-Cuesta J; Sabater L; Dalmau J; Maldonado R; Graus F
    J Neuroimmunol; 2013 Aug; 261(1-2):53-9. PubMed ID: 23726906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of myasthenia gravis with coexistence of anti-acetylcholine receptor antibodies and anti-P/Q-type VGCC antibodies].
    Takeda Y; Noda Y; Seike N; Ishihara H
    Rinsho Shinkeigaku; 2024 Apr; 64(4):292-295. PubMed ID: 38508730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lambert-Eaton myasthenic syndrome].
    Motomura M; Fukuda T
    Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lambert-Eaton Myasthenic Syndrome].
    Matsuo H
    Brain Nerve; 2024 May; 76(5):630-634. PubMed ID: 38741506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.